Tom Gallen

<p><span>Supply problems for Nestlé’s US dietary supplement brands “were more fundamental than initially we have estimated,” according to CEO Mark Schneider. Nestlé now expects the issue – first flagged up last year – won’t be fully resolved until the end of the first half of 2024.</span></p>

With Bayer “badly broken in four places,” now is not the right time to consider offloading its Consumer Health business, according to group CEO Bill Anderson. Bayer must focus its full attention for the next few years on addressing challenges which include mounting debt and costly litigation before a change to the company’s structure can be considered.

<span>Australian-heritage Swisse grew its share of China’s supplements market in 2023 by delivering tailored products to an increasingly health conscious population.</span>

By teaming up with local player Dr Reddy’s,&nbsp;<span>Nestlé is hoping to improve the distribution and reach of dietary supplement brands like Nature’s Bounty in India. The company announced its India joint venture as it reported Q1 sales down at its Health Science business.</span>

By teaming up with local player Dr Reddy’s,&nbsp;<span>Nestlé is hoping to improve the distribution and reach of dietary supplement brands like Nature’s Bounty in India. The company announced its India joint venture as it reported Q1 sales down at its Health Science business.</span>

Haleon gets its dietary supplements growth engine firing in Q1 with VMS sales up almost 10% as the firm’s three biggest brands record gains.

The increasing prevalence of psychedelic truffles sold as food supplements purported to enhance mood and boost creativity is of growing concern to the European Food Safety Authority. EFSA’s Milen Georgiev tells HBW Insight how the authority is handling this emerging risk to consumers.

<p>The increasing prevalence of psychedelic truffles sold as food supplements purported to enhance mood and boost creativity is of growing concern to the European Food Safety Authority. EFSA’s&nbsp;Milen Georgiev tells HBW Insight how the authority is handling this emerging risk to consumers.</p>

<p><span>Key challenges facing companies working to implement the European Sustainability Reporting Standards have been identified by the European Financial Reporting Advisory Group. Onur Durmus, Partner at sustainability consultancy ERM, shares his thoughts on EFRAG’s findings and offers takeaways for firms that will be subject to the EU’s Corporate Sustainability Reporting Directive.</span></p>

<p>Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&amp;R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.</p>